DrugPatentWatch Database Preview

Akorn Company Profile

AKORN has one hundred and sixty-eight approved drugs.

There is one US patent protecting AKORN drugs. There are three tentative approvals on AKORN drugs.

There are two patent family members on AKORN drugs in two countries and one hundred and seventy-nine supplementary protection certificates in twelve countries.

International Patents:	2
US Patents:	1
Tradenames:	133
Ingredients:	122
NDAs:	168
Patent Litigation for Akorn:	See patent lawsuits for Akorn
PTAB Cases with Akorn as petitioner:	See PTAB cases with Akorn as petitioner

Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Akorn	LORAZEPAM	lorazepam	INJECTABLE;INJECTION	075025-001	Jul 23, 1998	AP	RX	No	No		➤ Sign Up				➤ Sign Up
Akorn Inc	ACETYLCYSTEINE	acetylcysteine	INJECTABLE;INTRAVENOUS	203173-001	Mar 24, 2015	AP	RX	No	No		➤ Sign Up				➤ Sign Up
Akorn Inc	PHENYLEPHRINE HYDROCHLORIDE	phenylephrine hydrochloride	SOLUTION/DROPS;OPHTHALMIC	207926-001	Jan 15, 2015	AT	RX	Yes	Yes		➤ Sign Up				➤ Sign Up
Akorn	HALOPERIDOL	haloperidol lactate	INJECTABLE;INJECTION	204849-001	Sep 6, 2017	AP	RX	No	No		➤ Sign Up				➤ Sign Up
Akorn Inc	DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE	dorzolamide hydrochloride; timolol maleate	SOLUTION/DROPS;OPHTHALMIC	203058-001	Sep 22, 2014	AT	RX	No	No		➤ Sign Up				➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Akorn	ALFENTA	alfentanil hydrochloride	INJECTABLE;INJECTION	019353-001	Dec 29, 1986	4,167,574	➤ Sign Up
Akorn	SUFENTA PRESERVATIVE FREE	sufentanil citrate	INJECTABLE;INJECTION	019050-001	May 4, 1984	3,998,834	➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration

Subscribe to access the full database, or try a Free Trial
Country	Patent Number	Estimated Expiration
World Intellectual Property Organization (WIPO)	2008014036	➤ Sign Up
European Patent Office	2043601	➤ Sign Up
Country	Patent Number	Estimated Expiration

Subscribe to access the full database, or try a Free Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1441735	08C0026	France	➤ Sign Up	PRODUCT NAME: RALTEGRAVIR OU L(UN DE SES SELS PHARMACEUTIQUEMENT ACCCEPTABLES EN PARTICULIER UN SEL DE POTASSIUM; REGISTRATION NO/DATE IN FRANCE: EU/1/07/436/001 DU 20071220; REGISTRATION NO/DATE AT EEC: EU/1/07/436/001 DU 20071220
0473687	SPC/GB98/030	United Kingdom	➤ Sign Up	PRODUCT NAME: FOSPHENYTOIN SODIUM (3-HYDROXYMETHYL)-5,5-DIPHENYLHYDANTOIN DISODIUM PHOSPHATE ESTER); REGISTERED: UK 0019/0157 19980204
0239710	96C0042	Belgium	➤ Sign Up	PRODUCT NAME: CHLORHYDRATE DE ROPIVACAINE MONOHYDRATE; NAT. REGISTRATION NO/DATE: 212 IS 216 F 12 19960806; FIRST REGISTRATION: SE 12319 19950915
2957286	300962	Netherlands	➤ Sign Up	PRODUCT NAME: PATIROMER SORBITEX CALCIUM; REGISTRATION NO/DATE: EU/1/17/1179 20170721
0387077	SPC/GB04/003	United Kingdom	➤ Sign Up	PRODUCT NAME: PARICALCITOL; REGISTERED: ES SPAIN 64.974 20020809; UK PL 00037/0403 20030721
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.